Responding to queries by Human Resources on hiring plans, Foo Wah Teng, human resources director, Amgen Singapore Manufacturing, said: “The opening of Amgen’s Next-Generation Workplace (NGW) reinforces our commitment to develop and nurture local talent to deliver impact and value to better the health of people in Singapore. This opening presents a wide range of career opportunities for those aspiring to be part of the vibrant biomanufacturing scene in Singapore.
“Amgen also continues to collaborate with agencies such as the Singapore Economic Development Board and Workforce Singapore to develop a pipeline of specialists roles for Amgen and for the local biologics manufacturing sector through industry manpower development programs such as Development and Apprenticeship (DNA) and Local BOOST (Local Biologics Skills Training).”
Amgen yesterday (14 May) officially opened its new manufacturing support office, the NextGen Workplace, at the Tuas Biomedical Hub in Singapore. With this, the biotechnology company has now invested more than SGD$400 million into its Singapore operations.
Spanning more than 7,500 square meters, the NextGen Workplace will support both Amgen’s revolutionary NextGen Biomanufacturing and its Chemical Synthesis manufacturing facilities.
Designed to inspire innovation and collaboration, enhance productivity and to build a vibrant work culture to support the biotechnology company’s growth in Singapore; Amgen’s NextGen Workplace will play a pivotal role in attracting and retaining talented staff.
Boasting various collaboration spaces that encapsulate Amgen’s brand values, the new workplace engages employees with highly flexible activity-based work options to drive faster decisions, foster greater exploration of ideas and connect colleagues while integrating social spaces for employees to recharge.
Arleen Paulino, vice president, site operations at Amgen Singapore Manufacturing, said: “At Amgen, our aim is to always groom a future-ready workforce to transform the promise of science and biotechnology into therapies that fulfil our mission to serve patients around the world. Amgen’s NextGen Workplace in Singapore marks an important milestone in our ongoing journey to become more agile and patient-focused. This new workspace and our complementary work policies not only enhance our productivity and the way we work but will also support our efforts to create a workspace that is open, empowering and encourage collaboration.”
Ho Weng Si, director, biomedical sciences, Singapore Economic Development Board, said: “The expansion of Amgen’s local footprint is testament to Singapore’s strong track record for best-in-class pharmaceutical manufacturing. Singapore continues to see companies such as Amgen build on their existing presence here to manufacture new pharmaceutical products and adopt new manufacturing technologies. EDB remains committed to supporting the continued growth and talent development of the sector, to create good business and jobs opportunities.”
Ho also congratulated Amgen on its agile approach towards the future of work as seen in its NextGen Workplace, which is aligned with Singapore’s continued push for innovation and productivity.
Photo / Amgen